Page last updated: 2024-08-16

resveratrol and Astrocytoma

resveratrol has been researched along with Astrocytoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Antel, J; Gran, ER; Kakkar, A; Lotocki, V; Maysinger, D; Zhang, Q1
Gülden, M; Maser, E; Murias, M; Rüweler, M; Seibert, H1
Chang, CH; Chang, CJ; Chang, YL; Chen, MH; Chen, MT; Chiou, GY; Chiou, SH; Hsu, CC; Huang, PI; Ma, HI; Shih, YH; Tsai, LL; Tseng, LM; Wang, CT; Yang, YP; Yu, CC1
Aregullin, M; Berry, JP; Flanders, JA; Laux, MT; Rodriguez, E1
Choi, YH; Kim, GY; Kim, YA; Park, KY1
Anker, A; Gülden, M; Maser, E; Rüweler, M; Seibert, H1

Other Studies

6 other study(ies) available for resveratrol and Astrocytoma

ArticleYear
Human astrocytes and astrocytoma respond differently to resveratrol.
    Nanomedicine : nanotechnology, biology, and medicine, 2021, Volume: 37

    Topics: Antioxidants; Astrocytes; Astrocytoma; Cell Line, Tumor; Humans; Nanoparticles; Primary Cell Culture; Reactive Oxygen Species; Resveratrol; Single-Cell Analysis

2021
Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro.
    Chemico-biological interactions, 2009, Dec-10, Volume: 182, Issue:2-3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Astrocytoma; Cell Line, Tumor; Cell Proliferation; Free Radicals; Oxidative Stress; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes

2009
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
    Journal of cellular physiology, 2012, Volume: 227, Issue:3

    Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Humans; Male; Mice; Mice, SCID; Middle Aged; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2012
Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol.
    Journal of alternative and complementary medicine (New York, N.Y.), 2004, Volume: 10, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Astrocytoma; Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Resveratrol; Signal Transduction; Stilbenes; Time Factors; Transcriptional Activation; Tumor Suppressor Protein p53

2004
Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia.
    Journal of medicinal food, 2007, Volume: 10, Issue:2

    Topics: Animals; Astrocytoma; Cell Division; Cell Line, Tumor; Cell Nucleus; Cyclooxygenase 2; Dinoprostone; Gene Expression; Lipopolysaccharides; Microglia; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Resveratrol; Stilbenes

2007
Inhibition of peroxide-induced radical generation by plant polyphenols in C6 astroglioma cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2008, Volume: 22, Issue:5

    Topics: Astrocytoma; Benzene Derivatives; Brain Neoplasms; Dose-Response Relationship, Drug; Flavonoids; Free Radical Scavengers; Free Radicals; Genistein; Luteolin; Oxidants; Oxidative Stress; Phenols; Plant Extracts; Polyphenols; Resveratrol; Stilbenes

2008